Detalhe da pesquisa
1.
Improving Routine 89Zr-Immuno-PET Applications: Mild Iron Removal Can Favor the Use of Fe-DFO-N-suc-TFP Ester Over p-NCS-Bz-DFO.
J Labelled Comp Radiopharm
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744538
2.
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake.
Eur J Nucl Med Mol Imaging
; 50(7): 1897-1905, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820891
3.
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Eur J Nucl Med Mol Imaging
; 50(7): 2068-2080, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859619
4.
State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET.
Bioconjug Chem
; 32(7): 1315-1330, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974403
5.
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET.
Eur J Nucl Med Mol Imaging
; 48(3): 694-707, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889615
6.
An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody-Drug Conjugates.
Angew Chem Int Ed Engl
; 60(6): 3008-3015, 2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185916
7.
The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties.
J Biol Chem
; 294(44): 16297-16308, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519750
8.
The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.
Int J Mol Sci
; 21(3)2020 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32033160
9.
Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis.
Eur J Nucl Med Mol Imaging
; 46(9): 1840-1849, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209514
10.
F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach.
Mol Pharm
; 16(1): 273-281, 2019 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550295
11.
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET.
Eur J Nucl Med Mol Imaging
; 44(2): 286-295, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573793
12.
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
Eur J Nucl Med Mol Imaging
; 42(8): 1304-14, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25792453
13.
Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.
J Biol Chem
; 288(41): 29562-72, 2013 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23979133
14.
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.
Proc Natl Acad Sci U S A
; 108(35): 14620-5, 2011 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873245
15.
Good practices for 89Zr radiopharmaceutical production and quality control.
EJNMMI Radiopharm Chem
; 9(1): 40, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733556
16.
How to obtain the image-derived blood concentration from 89Zr-immuno-PET scans.
EJNMMI Phys
; 11(1): 16, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321232
17.
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET.
EJNMMI Res
; 14(1): 18, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358425
18.
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
EJNMMI Res
; 14(1): 19, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363422
19.
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor.
Nucl Med Biol
; 120-121: 108349, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209556
20.
Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase.
J Med Chem
; 66(17): 12130-12140, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647220